Sexually Transmitted Diseases: Diagnosis and Work-Up (GC, Chlamydia, Herpes HPV)

Living reference work entry

Abstract

There is an array of tests available to diagnose each of the above sexually transmitted diseases. Each test has its own sensitivity, specificity, and specific clinical situation for which it is ideally situated. Nucleic acid amplification tests (NAATs) tend to have the highest sensitivity and specificity when testing for gonorrhea and chlamydia. However, depending on the clinical scenario and site to be tested, there may be other tests which are better suited. Testing for HSV lesions has variable sensitivity and specificity based on the time interval between testing and outbreak and amount of viral shedding. To negate this variability, indirect testing which exams the patient’s blood for antibodies to HSV has been created. This test can detect antibodies against HSV, even after lesions have resolved. The human papillomavirus is extremely prevalent worldwide. Cytology and HPV co-testing still remain the gold standard for diagnosing and triaging HPV. A thorough knowledge of the common presentation, available testing, and current treatments is essential for all healthcare providers. Early detection, diagnosis, and treatment will prevent continued spread to other parties and decrease morbidity in patients.

The purpose of this chapter is to present the current standards for diagnosis and treatment of sexually transmitted diseases. In this text, presentation, diagnosis, and treatment of the sexually transmitted diseases, gonorrhea, chlamydia, herpes simplex virus, and human papillomavirus, are discussed. In order to obtain the most current and accurate data, a comprehensive literature review was performed for each of the abovementioned sexually transmitted diseases in regard to presentation, available screening and diagnostic testing, and treatment. The CDC database was cross-referenced to confirm concordance in the treatment of the abovementioned sexually transmitted diseases.

Keywords

Gonorrhea Chlamydia Human papillomavirus Herpes simplex virus Screening Sexually transmitted infections 

References

  1. ACOG Committee Opinion Expedited Partner Therapy in the Management of Gonorrhea and Chlamydia Infection. Number 632, June 2015.Google Scholar
  2. Bignell C, Ison C, Jungmann C. Gonorrhea Sex Transm Infect. 2006;82(Suppl IV):iv6–9.PubMedGoogle Scholar
  3. Bleich AT, Sheffield JS, Wendel Jr GD, Sigman A, Cunningham FG. Disseminated gonococcal infection in women. Obstet Gynecol. 2012;119(3):597–602.CrossRefPubMedGoogle Scholar
  4. Carder C, Mercey D, Benn P. Chlamydia trachomatis. Sex Transm Infect. 2006;82(Suppl IV):iv10–2.PubMedPubMedCentralGoogle Scholar
  5. Center for Disease Control and Prevention. 2010 STD treatment guidelines gonococcal infections [Internet]. 2010. Updated 2011. Cited 2015. Available from: http://www.cdc.gov/std/treatment/2010/gonococcal-infections.htm
  6. Centers for Disease Control and Prevention. CDC fact sheet: incidence, prevalence, and cost of sexually transmitted infections in the United States. 2013. Updated Feb 2013. Available from: http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf
  7. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae-2014. Updated Mar 2014. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm
  8. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2015. 2015a. Updated June 2015.Google Scholar
  9. Centers for Disease Control and Prevention. Human papillomavirus treatment and care 2013. Updated Oct 2015b. Available from http://www.cdc.gov/std/hpv/treatment.htm
  10. Eckert L, Lentz G. Infections of the lower and upper genital tracts. In: Lentz, comprehensive gynecology. 6th ed. St. Louis, MO: Mosby/Elsevier Publishing; 2012.Google Scholar
  11. McCredie MR, Sharpies KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Uncool. 2008;9:425Y34.Google Scholar
  12. Nishino HT, Tambouret RH, Wilbur DC. Testing for human papillomavirus in cervical cancer screening. Cancer Cytopathol. 2011;119:219–27. doi:10.1002/cncy.20161.CrossRefPubMedGoogle Scholar
  13. Oh S, Longworth M, Laminins L. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol. 2005;78:2620–6.CrossRefGoogle Scholar
  14. Papp JR, Schachter J, Gaydos C, et al. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae – 2014. MMWR Recomm Rep. 2014;63:1–19.PubMedCentralGoogle Scholar
  15. Patient Education Fact Sheet, New Guidelines for Cervical Cancer Screening. 2–13 Sept 2013. www.acog.org/-/media/For-Patients/pfs004.pdf?dmc=1&ts=20161104T1252367166. Last accessed 3 Nov 2016.
  16. Saslow D, Solomon D, Herschel W, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Lower Genital Tract Dis. 2012;16:175–204.CrossRefGoogle Scholar
  17. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis. 2005;32:725–8.CrossRefPubMedGoogle Scholar
  18. Singh A, Preiksaitis J, Romano ski B. The laboratory diagnosis of herpes simplex virus infections. Can J Infect Dis Med Microbial. 2005;16(2):92–8.Google Scholar
  19. Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med. 2008;168:1881Y9.CrossRefGoogle Scholar
  20. Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diagn Ther. 2006;10(1):17–28.CrossRefPubMedGoogle Scholar
  21. Todar K.. The normal bacterial Flora of humans [internet]. Textbook of bacteriology. 2012.Google Scholar
  22. United States Preventative Services Task Force. Screening for chlamydia and gonorrhea 2014. Updated Dec 2014Google Scholar

Copyright information

© Springer International Publishing AG (outside the USA) 2016

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations